MCID: PRT029
MIFTS: 41

Parathyroid Adenoma malady

Categories: Genetic diseases, Cancer diseases, Endocrine diseases, Rare diseases

Aliases & Classifications for Parathyroid Adenoma

About this section

Aliases & Descriptions for Parathyroid Adenoma:

Name: Parathyroid Adenoma 10 47 12 65
Adenoma of the Parathyroid Gland 10
 
Adenoma of Parathyroid 10

Classifications:



External Ids:

Disease Ontology10 DOID:7608
MeSH36 D010282
SNOMED-CT59 128474007
NCIt42 C3916
UMLS65 C0262587

Summaries for Parathyroid Adenoma

About this section
Wikipedia:68 A parathyroid adenoma is a benign tumor of the parathyroid gland. It generally causes... more...

MalaCards based summary: Parathyroid Adenoma, also known as adenoma of the parathyroid gland, is related to mixed cell type adenoma of parathyroid and hyperparathyroidism-jaw tumor syndrome. An important gene associated with Parathyroid Adenoma is CCND1 (Cyclin D1), and among its related pathways are Thyroid cancer and Transcription_Role of VDR in regulation of genes involved in osteoporosis. Affiliated tissues include breast, endothelial and prostate, and related mouse phenotypes are respiratory system and digestive/alimentary.

Related Diseases for Parathyroid Adenoma

About this section

Diseases in the Parathyroid Adenoma family:

Familial Parathyroid Adenoma

Diseases related to Parathyroid Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 470)
idRelated DiseaseScoreTop Affiliating Genes
1mixed cell type adenoma of parathyroid33.8ALPP, MEN1, PTH
2hyperparathyroidism-jaw tumor syndrome31.6CASR, CCND1, CDC73, MEN1, RET
3dementia30.6CASR, PTH
4parathyroid carcinoma30.4CASR, CCND1, CDC73, MEN1, PTH
5nephrocalcinosis29.8CASR, CDC73, PTH, PTHLH
6familial parathyroid adenoma12.5
7chief cell adenoma11.5
8multiple endocrine neoplasia iia10.4
9birt-hogg-dube syndrome10.4
10hyperparathyroidism10.4
11osteitis fibrosa10.4
12leukemia10.4
13somatoform disorder10.3CASR, PTH
14bone inflammation disease10.3CASR, PTH
15hyperparathyroidism 310.3CDC73, MEN1
16hyperparathyroidism, familial primary10.3CDC73, MEN1
17fibrogenesis imperfecta ossium10.3ALPP, PTH
18uremia10.3ALPP, PTH
19endotheliitis10.3
20diabetic angiopathy10.3ALPP, PTH
21breast cancer10.3
22glossopharyngeal nerve paralysis10.2PTH, PTHLH
23bone structure disease10.2ALPP, PTH
24giant cell reparative granuloma10.2PTH, PTHLH
25colorectal cancer10.2
26pediculus humanus corporis infestation10.2ALPP, PTHLH
27craniodiaphyseal dysplasia10.2ALPP, CDC73
28epileptic encephalopathy, early infantile, 2610.2PTH, PTHLH
29antley-bixler syndrome10.2CASR, PTH
30arthritis10.2
31hepatitis10.2
32prostatitis10.2
33purpura10.2
34cerebritis10.2
35bronchus adenoma10.2MEN1, PTHLH
36anus basaloid carcinoma10.2PTH, PTHLH
37marcus gunn phenomenon10.1ALPP, PTHLH
38central hypoventilation syndrome, congenital10.1MEN1, RET
39epidermolysis bullosa, pretibial10.1PTH, PTHLH
40asthma10.1
41lymphoma10.1
42thrombotic thrombocytopenic purpura10.1
43melanoma10.1
44cervicitis10.1
45adenocarcinoma10.1
46thyroiditis10.1
47neuronitis10.1
48hypoxia10.1
49serous labyrinthitis10.1PTH, PTHLH
50congenital nervous system abnormality10.1ALPP, CASR, PTH

Graphical network of the top 20 diseases related to Parathyroid Adenoma:



Diseases related to parathyroid adenoma

Symptoms for Parathyroid Adenoma

About this section

Drugs & Therapeutics for Parathyroid Adenoma

About this section

Drugs for Parathyroid Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cholineapproved, nutraceuticalPhase 213062-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
2AntimetabolitesPhase 29454
3Hypolipidemic AgentsPhase 22228
4Nootropic AgentsPhase 2604
5Gastrointestinal AgentsPhase 26401
6
PaclitaxelapprovedPhase 1262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
7
Trastuzumabapproved, investigationalPhase 1726180288-69-19903
Synonyms:
180288-69-1
Anti HER2
Anti-erbB2 Monoclonal Antibody
D03257
HER2 Monoclonal Antibody
Herceptin
 
Herceptin (TN)
Ig gamma-1 chain C region
Trastuzumab
Trastuzumab (INN)
Trastuzumab (genetical recombination)
Trastuzumab (genetical recombination) (JAN)
trastuzumab
8
CarboplatinapprovedPhase 1188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
9Immunologic FactorsPhase 118483
10Tubulin ModulatorsPhase 14279
11Interleukin-12Phase 1125
12Antineoplastic Agents, PhytogenicPhase 14294
13Antimitotic AgentsPhase 14296
14Albumin-Bound PaclitaxelPhase 12621
15Adjuvants, ImmunologicPhase 11783
16Angiogenesis Modulating AgentsPhase 13611
17Angiogenesis InhibitorsPhase 13688
18Hormones11748
19Calcium, Dietary4678
20Anesthetics7385
21vitamin d1524
22Vitamins3857

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid AdenomasRecruitingNCT02432599Phase 2
2Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
3Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment ProcedureCompletedNCT01060982
4Using X-Ray Dye to Locate Hidden Parathyroid TumorsCompletedNCT00001394
5Open Versus Video-Assisted Minimal-Invasive Parathyroid SurgeryCompletedNCT00877981
6Anti-3-[18F]FACBC Imaging of Parathyroid AdenomasRecruitingNCT01574287
7Differentially Expressed Proteins in Sporadic Parathyroid TumorsRecruitingNCT01647503
8Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary HyperparathyroidismRecruitingNCT01228786
9Minimally Invasive Radioguided ParathyroidectomyRecruitingNCT01530919
10The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural MesotheliomaRecruitingNCT01776385
11Surgical Approach for Primary Hyperparathyroidism in the ElderlyActive, not recruitingNCT01484379
12Input of C11-Choline PET/CT in Localization of Parathyroid AdenomaNot yet recruitingNCT01221896
13Evaluation of a New CZT SystemNot yet recruitingNCT01084356
14High Intensity Focused Ultrasound (HIFU) for Parathyroid AdenomaTerminatedNCT01291498
15Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid AdenomasTerminatedNCT00639405
16Multicenter Registry Comparing Preoperative Imaging for Primary HyperparathyroidismWithdrawnNCT02381925

Search NIH Clinical Center for Parathyroid Adenoma

Genetic Tests for Parathyroid Adenoma

About this section

Anatomical Context for Parathyroid Adenoma

About this section

MalaCards organs/tissues related to Parathyroid Adenoma:

33
Breast, Endothelial, Prostate, Lung, Heart, T cells, Brain

Animal Models for Parathyroid Adenoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Parathyroid Adenoma:

38 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.4CCND1, CDC73, CDKN2C, PTHLH, RET
2MP:00053818.4CASR, CCND1, CDC73, MEN1, PTHLH, RET
3MP:00053677.7CASR, CDC73, CDKN2C, CHGA, PTHLH, RET
4MP:00053847.5CASR, CCND1, CDC73, CDKN2C, MEN1, PTHLH
5MP:00053897.5CCND1, CDC73, CDKN2C, CHGA, MEN1, PTHLH
6MP:00053977.3CASR, CCND1, CDC73, CDKN2C, PTH, PTHLH
7MP:00053796.8CASR, CCND1, CDC73, CDKN2C, CHGA, MEN1
8MP:00053856.7CCND1, CDC73, CDKN2C, CHGA, MEN1, PTH
9MP:00053876.6CASR, CCND1, CDC73, CDKN2C, MEN1, PTH
10MP:00053766.6CASR, CCND1, CDC73, CDKN2C, CHGA, MEN1
11MP:00107686.5CASR, CCND1, CDC73, CDKN2C, CHGA, MEN1
12MP:00053786.5CASR, CCND1, CDC73, CDKN2C, CHGA, MEN1

Publications for Parathyroid Adenoma

About this section

Articles related to Parathyroid Adenoma:

(show top 50)    (show all 643)
idTitleAuthorsYear
1
The bizzare phenomenon of smokers' paradox in the immediate outcome post acute myocardial infarction: an insight into the Malaysian National Cardiovascular Database-Acute Coronary Syndrome (NCVD-ACS) registry year 2006-2013. (27186498)
2016
2
Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis. (27193134)
2016
3
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. (24970803)
2014
4
Supermicrosurgical anastomosis of superficial lymphatic vessel to deep lymphatic vessel for a patient with cellulitis-induced chronic localized leg lymphedema. (25197031)
2014
5
Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats. (24297321)
2014
6
Evaluation of neural damage in Duchenne muscular dystrophy patients. (25291916)
2014
7
Isolated hepatobiliary cryptococcosis manifesting as obstructive jaundice in an immunocompetent child: case report and review of the literature. (23942746)
2013
8
Cerebrospinal fluid levels of leptin, proopiomelanocortin, and agouti-related protein in human pregnancy: evidence for leptin resistance. (23118421)
2013
9
Polymicrogyria with dysmorphic basal ganglia? Think tubulin! (23495813)
2013
10
Transcriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growth. (21765909)
2011
11
Cardiac magnetic resonance aids in the diagnosis of mitochondrial cardiomyopathy. (21321176)
2011
12
A modified formulation of Chinese traditional medicine improves memory impairment and reduces AI^ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. (21762767)
2011
13
Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. (21844484)
2011
14
Oncogenic potential of yin yang 1 mediated through control of imprinted genes. (22248054)
2011
15
Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy. (21899988)
2011
16
Characterization of phospholipase C gamma enzymes with gain-of-function mutations. (19531496)
2009
17
Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study. (19531755)
2009
18
Chest wall desmoid tumor with life-threatening intrathoracic extension. (19162501)
2009
19
Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. (17296834)
2007
20
Spindle cell lipoma of the spermatic cord. (17956535)
2007
21
Thin basement membrane nephropathy associated with minimal change disease in a 15-year-old boy. (16362391)
2006
22
Differential gene regulation by selective association of transcriptional coactivators and bZIP DNA-binding domains. (16880509)
2006
23
Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands. (17032651)
2006
24
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. (15753437)
2005
25
Impact of metastatic estrogen receptor and progesterone receptor status on survival. (15770528)
2005
26
Unilateral exophthalmos caused by an extramedullary plasmacytoma: a case report. (23365508)
2003
27
p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. (12499437)
2003
28
Captopril and vascular endothelial growth factor in a mouse model of retinopathy. (14632165)
2003
29
Cutaneous anthrax of the eyelid. (17642834)
2003
30
Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. (14707827)
2003
31
A protective role for endothelial nitric oxide synthase in glomerulonephritis. (11849432)
2002
32
First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18. (11559905)
2001
33
Genetic association between rheumatoid arthritis and estrogen receptor microsatellite polymorphism. (10914844)
2000
34
Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas. (11281375)
2000
35
Phosphorylation of MYPT1 by protein kinase C attenuates interaction with PP1 catalytic subunit and the 20 kDa light chain of myosin. (11068043)
2000
36
Primary antiphospholipid syndrome and cerebral atrophy: a rare association? (10372845)
1999
37
Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies. (9209363)
1997
38
L-ascorbic acid inhibits UVA-induced lipid peroxidation and secretion of IL-1alpha and IL-6 in cultured human keratinocytes in vitro. (9036929)
1997
39
Involvement of the CCND1 gene in hairy cell leukemia. (8740788)
1996
40
Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. (8628286)
1996
41
Familial dysalbuminaemic hyperthyroxinaemia and inherited partial TBG deficiency: first report. (8033365)
1994
42
Echocardiographic assessment of subvalvular aortic stenosis before and after operation. (1552088)
1992
43
Acute basophilic leukemia. A case report. (1718580)
1991
44
In situ localization of the human multidrug-resistance gene mRNA using thymine-thymine dimerized single-stranded cDNA. (1977730)
1990
45
Expression of IgE from a nonrearranged epsilon locus in cloned B-lymphoblastoid cells that also express IgM. (2109779)
1990
46
Type-I hypersensitivity as a component of eosinophilic myositis (muscular sarcocystosis) in cattle. (2496630)
1989
47
Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family. (3670288)
1987
48
Is Hauser a harmless procedure? A biomechanical study of the patellofemoral joint, related to the development of secondary chondromalacia. (6751019)
1982
49
Induction of fasting hypoglycemia and hyperinsulinemia in the mouse by pituitary and urinary peptides. (4320761)
1970
50
HYDROCELE. (14343385)
1965

Variations for Parathyroid Adenoma

About this section

Expression for genes affiliated with Parathyroid Adenoma

About this section
Search GEO for disease gene expression data for Parathyroid Adenoma.

Pathways for genes affiliated with Parathyroid Adenoma

About this section

GO Terms for genes affiliated with Parathyroid Adenoma

About this section

Biological processes related to Parathyroid Adenoma according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1cAMP metabolic processGO:004605810.3PTH, PTHLH
2osteoblast developmentGO:000207610.1MEN1, PTHLH
3response to fibroblast growth factorGO:007177410.0CASR, PTH
4beta-catenin-TCF complex assemblyGO:190483710.0CDC73, MEN1
5response to calcium ionGO:005159210.0CASR, CCND1
6cellular response to glucose stimulusGO:00713339.9CASR, MEN1
7negative regulation of transcription from RNA polymerase II promoterGO:00001229.1CCND1, CDC73, MEN1, PTH
8mitotic cell cycleGO:00002789.0CCND1, CDKN2C, MEN1

Sources for Parathyroid Adenoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet